iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionCarret Asset Management, Llc
Latest Disclosed Ownership2,449 shares
Latest Disclosed Value $ 413,514
Carret Asset Management, Llc ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Carret Asset Management, Llc filed a 13F-HR form disclosing ownership of 2,449 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $413,514 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,449 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $320,941 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,449 0 0.00 414 0.00 0.0405
2026-02-17 2025-12-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,449 5 0.20 413 17.33 0.0392
2025-11-13 2025-09-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,444 0 0.00 353 13.92 0.0343
2025-08-04 2025-06-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,444 -125 -4.87 309 -5.79 0.0330
2025-04-22 2025-03-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,569 -213 -7.66 329 -10.63 0.0371
2025-02-10 2024-12-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,782 -22 -0.78 368 -10.05 0.0403
2024-10-24 2024-09-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,804 0 0.00 408 6.25 0.0443
2024-08-01 2024-06-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,804 -9 -0.32 385 -0.52 0.0449
2024-04-19 2024-03-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,813 -120 -4.09 386 -3.02 0.0455
2024-02-02 2023-12-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,933 -85 -2.82 398 7.86 0.0508
2023-10-12 2023-09-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 3,018 50 1.68 369 -1.86 0.0514
2023-07-25 2023-06-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,968 -100 -3.26 377 -5.05 0.0500
2023-05-11 2023-03-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 3,068 -310 -9.18 396 0.0550
2023-01-10 2022-12-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 3,378 -95 -2.74 0 -100.00 0.0612
2022-11-14 2022-09-30 13F/A-1 ISHARES NASDAQ BIOTECH INDX ETF 464287556 3,473 -360 -9.39 406 -9.98 0.0606
2022-10-11 2022-09-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 3,473 -360 406 0.0606
2022-08-04 2022-06-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 3,833 5 0.13 451 -9.62 0.0626
2022-04-13 2022-03-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 3,828 -150 -3.77 499 -17.79 0.0571
2022-01-10 2021-12-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 3,978 -9 -0.23 607 -5.89 0.0672
2021-10-27 2021-09-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 3,987 -535 -11.83 645 -12.84 0.0770
2021-07-14 2021-06-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 4,522 -79 -1.72 740 6.78 0.0866
2021-07-14 2021-03-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 4,601 0 0.00 693 -0.57 0.0860
2021-03-16 2020-12-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 4,601 -6 -0.13 697 11.70 0.0938
2020-11-16 2020-09-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 4,607 477 11.55 624 10.44 0.0943
2020-08-12 2020-06-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 4,130 145 3.64 565 31.70 0.0916
2020-05-18 2020-03-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 3,985 -225 -5.34 429 -15.38 0.0823
2020-02-13 2019-12-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 4,210 732 21.05 507 46.53 0.0740
2019-11-13 2019-09-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 3,478 632 22.21 346 11.61 0.0549
2019-08-12 2019-06-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,846 250 9.63 310 6.90 0.0492
2019-05-15 2019-03-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,596 65 2.57 290 18.85 0.0473
2019-02-13 2018-12-31 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 2,531 700 38.23 244 9.42 0.0440
2018-11-13 2018-09-30 13F ISHARES NASDAQ BIOTECH INDX ETF 464287556 1,831 1,831 223 0.0343
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.